ADMA Biologics ADMA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's operating lease ROU assets?
- ADMA Biologics (ADMA) reported operating lease ROU assets of $6.4M in Q1 2026.
- How has ADMA Biologics's operating lease ROU assets changed year-over-year?
- ADMA Biologics's operating lease ROU assets decreased by 20.2% year-over-year, from $8.02M to $6.4M.
- What is the long-term trend for ADMA Biologics's operating lease ROU assets?
- Over 5 years (2020 to 2025), ADMA Biologics's operating lease ROU assets has grown at a 9.3% compound annual growth rate (CAGR), from $4.26M to $6.65M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.